MedTrace Logo

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

NCT01474811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13559

Last updated 2024-02-28

No results posted yet for this study

Summary

The primary purpose of the HCV-TARGET study is to establish a nationwide registry of patients undergoing treatment with antiviral therapies for chronic hepatitis C (HCV) at both academic and community practices.

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • University of Florida

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Michael W. Fried, M.D. · University of North Carolina, Chapel Hill

  • David R. Nelson, M.D. · University of Florida

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2022-09-09
Completion
2022-09-09

Countries

  • United States
  • Canada
  • Germany
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01474811 on ClinicalTrials.gov